Evidence check: hsCRP in the context of Blutzucker

High-sensitivity C-reactive protein (hsCRP) measures low-grade inflammation and is commonly linked to cardiovascular risk. In the context of blood sugar (glucose regulation, insulin resistance), observational evidence suggests that elevated hsCRP is associated with impaired glucose tolerance and type 2 diabetes, likely via chronic low-grade inflammation. However, hsCRP is not a direct marker of blood sugar; the evidence is predominantly from observational studies, not RCTs. Clinical relevance for individuals is limited because many confounders (obesity, physical activity, diet) affect both hsCRP and blood glucose. An elevated hsCRP alone does not warrant specific glucose-lowering therapy. Consumer lab tests offering hsCRP should be interpreted as a screening hint, not a diagnosis. Abnormal values require medical follow-up. Evidence: human-moderate. Caveat: No causal relationship; lifestyle interventions can lower both parameters.